Part-Time

Inpatient Speech Pathologist PD

Brown University Health

Brown University Health

1-10 employees

Remote behavioral health care platform analytics

Compensation Overview

$35.90 - $59.23/hr

Providence, RI, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Master’s degree in Speech-Language Pathology from an accredited institution
  • State License issued by the Rhode Island Department of Health, or Provisional Rhode Island State License for Clinical Fellows involved in supervised clinical fellowship year
  • Certificate of Clinical Competence from the American Speech-Language-Hearing Association (ASHA)
  • Evidence of pursuit of ASHA certification for clinical fellows
  • One to two years’ experience or eligibility for provisional license from the State of Rhode Island; Clinical Fellows will be considered
  • Fit for duty in accordance with OSHA standards and program specific needs
  • Performs independently within the department’s policies and practices
  • Independently sets goals for professional development
Responsibilities
  • Evaluates speech, voice, language, feeding/swallowing, and/or cognitive impairments
  • Establishes diagnosis, prognosis, and individualized plans of care
  • Implements treatment intervention based on plan of care, considering precautions, indications, and contradictions
  • Directs and coordinates patients’ rehabilitation plan of care
  • Evaluates patients’ progress and revises goals and plan of care accordingly
  • Educates and trains patients/caregivers
  • Anticipates and communicates discharge/home needs and resources
  • Completes documentation and charges timely and accurately, in compliance with department policy
  • Completes clinical documentation reflecting eligibility/ medical necessity of services in compliance with professional and regulatory standards
  • Consistently applies evidence-based practice to all aspects of clinical care
  • Seeks additional guidance when necessary to assure safe and effective patient care
  • Recommends and refers for additional diagnostic testing and/or services
  • Develops, selects, and prescribes multimodal augmentative and alternative communication systems, including unaided strategies (e.g., manual signs/gestures) and aided strategies (e.g., speech-generating devices, manual communication boards, picture schedules)
  • Selects, fits, and establishes effective use of appropriate prostheticadaptive devices for communication and swallowing (e.g. electrolarynges, speaking valves.)
  • Uses instrumental technology to diagnose and treat disorders of communication and swallowing (e.g. Videofluoroscopy for speech and swallowing, Fiberoptic Endoscopic Evaluation of Swallowing, Videostroboscopy, Videnonasophagyngoscopy, neuromuscular electrical stimulation, computer technology)
  • Services patients and their families/caregivers with hearing loss (e.g., auditory training for patients with cochlear implants and hearing aids; speech and language intervention secondary to hearing loss)
  • Provides assessment and intervention for patients diagnosed with auditory processing disorders
  • Screens patients for hearing loss or middle ear pathology using conventional pure-tone air conduction methods
  • Modifies and/or enhances communication performance (e.g., accent modification, care and improvement of the professional voice)
  • Complies with hospital and departmental policies and guidelines
  • Participates in strategic departmental quality improvement initiatives
  • Provides education to other hospital departments/personnel, students, and outside agencies/schools
  • Demonstrates ability to flex schedule based on department, patient, and/or caregiver need
  • Determines priorities according to departmental and patient care need
  • Participates in community based professional events
  • Participates in ongoing educational activities
  • Supports and promotes departmental teamwork
  • Completes mandatory departmental and hospital training on time
Brown University Health

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Multi-million dollar annual investments expand academic-clinical integration.
  • Rhode Island Hospital and Bradley specialize in behavioral health training.
  • Outpatient networks align with home-based behavioral care coordination.

What critics are saying

  • TriZetto cyber incident disrupts Brown University Health billing March 2026.
  • Lyra Health erodes employer behavioral health market share in New England.
  • Medicaid redetermination disenrolls 20-30% behavioral patients ongoing.

What makes Brown University Health unique

  • STAT program offers free certification for entry-level healthcare roles.
  • Exclusive teaching affiliate of Warren Alpert Medical School at Rhode Island Hospital.
  • Community Health Institute delivers Rhode Island-focused proactive care initiatives.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Brown University Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Paid Sick Leave

Productivity Bonus

Stock Options

Company Equity

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Loan Assistance

Professional Development Budget

Education allowance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Commuter Benefits

Meal Benefits

Medical Insurance

Life Insurance

Disability Insurance

Company News

PBN
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

PBN
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

PBN
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

PBN
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System